These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 36169955)
1. Association of Influenza Vaccination With SARS-CoV-2 Infection and Associated Hospitalization and Mortality Among Patients Aged 66 Years or Older. Hosseini-Moghaddam SM; He S; Calzavara A; Campitelli MA; Kwong JC JAMA Netw Open; 2022 Sep; 5(9):e2233730. PubMed ID: 36169955 [TBL] [Abstract][Full Text] [Related]
2. Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer. Gong IY; Vijenthira A; Powis M; Calzavara A; Patrikar A; Sutradhar R; Hicks LK; Wilton D; Singh S; Krzyzanowska MK; Cheung MC JAMA Oncol; 2023 Mar; 9(3):386-394. PubMed ID: 36580318 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study. Ray JG; Park AL BMJ Open; 2022 Jul; 12(7):e059944. PubMed ID: 35851010 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection, Hospitalization, and Mortality in Adults With and Without Cancer. Hosseini-Moghaddam SM; Shepherd FA; Swayze S; Kwong JC; Chan KKW JAMA Netw Open; 2023 Aug; 6(8):e2331617. PubMed ID: 37651139 [TBL] [Abstract][Full Text] [Related]
5. Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes. Buchan SA; Chung H; Brown KA; Austin PC; Fell DB; Gubbay JB; Nasreen S; Schwartz KL; Sundaram ME; Tadrous M; Wilson K; Wilson SE; Kwong JC JAMA Netw Open; 2022 Sep; 5(9):e2232760. PubMed ID: 36136332 [TBL] [Abstract][Full Text] [Related]
6. A Nationwide Cohort Study of Delta and Omicron SARS-CoV-2 Outcomes in Vaccinated Individuals With Chronic Lung Disease. Wee LE; Tan JYJ; Chiew CJ; Abisheganaden JA; Chotirmall SH; Lye DCB; Tan KB Chest; 2024 Oct; 166(4):685-696. PubMed ID: 38871281 [TBL] [Abstract][Full Text] [Related]
7. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study. Piernas C; Patone M; Astbury NM; Gao M; Sheikh A; Khunti K; Shankar-Hari M; Dixon S; Coupland C; Aveyard P; Hippisley-Cox J; Jebb SA Lancet Diabetes Endocrinol; 2022 Aug; 10(8):571-580. PubMed ID: 35780805 [TBL] [Abstract][Full Text] [Related]
8. Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine. McGrath LJ; Malhotra D; Miles AC; Welch VL; Di Fusco M; Surinach A; Barthel A; Alfred T; Jodar L; McLaughlin JM JAMA Netw Open; 2023 Nov; 6(11):e2342151. PubMed ID: 37938846 [TBL] [Abstract][Full Text] [Related]
9. First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death. Russo AG; Faccini M; Decarli A; Cattaneo S; Tunesi S; Murtas R; Fagandini F; Bergamaschi W Epidemiol Prev; 2022; 46(5-6):324-332. PubMed ID: 36341584 [TBL] [Abstract][Full Text] [Related]
10. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193 [TBL] [Abstract][Full Text] [Related]
11. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers. Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis. Smith JB; Gonzales EG; Li BH; Langer-Gould A JAMA Netw Open; 2022 Dec; 5(12):e2248664. PubMed ID: 36576740 [TBL] [Abstract][Full Text] [Related]
13. Autoimmune Sequelae After Delta or Omicron Variant SARS-CoV-2 Infection in a Highly Vaccinated Cohort. Wee LE; Lim JT; Tay AT; Chiew CJ; Ong B; Lye DCB; Lahiri M; Tan KB JAMA Netw Open; 2024 Aug; 7(8):e2430983. PubMed ID: 39212988 [TBL] [Abstract][Full Text] [Related]
14. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021. Steele MK; Couture A; Reed C; Iuliano D; Whitaker M; Fast H; Hall AJ; MacNeil A; Cadwell B; Marks KJ; Silk BJ JAMA Netw Open; 2022 Jul; 5(7):e2220385. PubMed ID: 35793085 [TBL] [Abstract][Full Text] [Related]
15. Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans. Young-Xu Y; Korves C; Roberts J; Powell EI; Zwain GM; Smith J; Izurieta HS JAMA Netw Open; 2021 Oct; 4(10):e2128391. PubMed ID: 34613401 [TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection. Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans. Laniece Delaunay C; Mazagatos C; Martínez-Baz I; Túri G; Goerlitz L; Domegan L; Meijer A; Rodrigues AP; Sève N; Ilic M; Latorre-Margalef N; Lazar M; Maurel M; Melo A; Andreu Ivorra B; Casado I; Horváth JK; Buda S; Bennett C; de Lange M; Guiomar R; Enouf V; Mlinaric I; Samuelsson Hagey T; Dinu S; Rumayor M; Castilla J; Oroszi B; Dürrwald R; O'Donnell J; Hooiveld M; Gomez V; Falchi A; Kurecic Filipovic S; Dillner L; Popescu R; Bacci S; Kaczmarek M; Kissling E; JAMA Netw Open; 2024 Jul; 7(7):e2419258. PubMed ID: 38949812 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of COVID-19 Infection in People Previously Vaccinated Against Influenza: Population-Based Cohort Study Using Primary Health Care Electronic Records. Giner-Soriano M; de Dios V; Ouchi D; Vilaplana-Carnerero C; Monteagudo M; Morros R JMIR Public Health Surveill; 2022 Nov; 8(11):e36712. PubMed ID: 36265160 [TBL] [Abstract][Full Text] [Related]
19. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden. Nordström P; Ballin M; Nordström A Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962 [TBL] [Abstract][Full Text] [Related]
20. Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19-Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021. Muhsen K; Maimon N; Mizrahi AY; Varticovschi B; Bodenheimer O; Cohen D; Dagan R JAMA Netw Open; 2022 Jul; 5(7):e2219940. PubMed ID: 35796153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]